Arizona Sci-Tech Gazette
SEE OTHER BRANDS

Your best source on science and technology news from Arizona

Arizona Sci-Tech Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arizona Sci-Tech Gazette.

Press releases published on September 3, 2025

Synopsis and Telnyx Partner to Deliver Scalable Communications and Voice AI Across MENA

Synopsis and Telnyx Partner to Deliver Scalable Communications and Voice AI Across MENA

AUSTIN, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Telnyx, the full-stack conversational AI platform powering global communications, is proud to announce a new partnership with Synopsis, a leading technology distributor in the Middle East and Africa (MEA). This …

Een veerkrachtige onderneming bouwen die hoge beschikbaarheid combineert met noodherstel

Een veerkrachtige onderneming bouwen die hoge beschikbaarheid combineert met noodherstel

Amsterdam, Nederland. September 2025 - Sean Tilley, EMEA Sales Director bij 11:11 Systems, een leverancier van beheerde infrastructuuroplossingen, deelt zijn inzichten over hoe bedrijven hun bedrijfskritische workloads kunnen moderniseren en beschermen met …

Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for August 2025 of its Virtune Crypto Altcoin Index ETP

Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for August 2025 of its Virtune Crypto Altcoin Index ETP

Stockholm, 3rd of August 2025 – Virtune AB (Publ) ("Virtune") today announces that it has completed the monthly rebalancing of the Virtune Crypto Altcoin Index ETP, listed on Nasdaq Stockholm and Nasdaq Helsinki (ISIN code SE0023260716). In addition to the …

Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för augusti 2025 av Virtune Crypto Altcoin Index ETP

Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för augusti 2025 av Virtune Crypto Altcoin Index ETP

Stockholm, 3 augusti 2025 – Virtune meddelar idag att man har slutfört den månatliga rebalanseringen av Virtune Crypto Altcoin Index ETP, noterad på Nasdaq Stockholm och Nasdaq Helsinki (ISIN-kod SE0023260716). Utöver Virtune Crypto Altcoin Index ETP …

Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor

Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor

Lehi, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah, September 3, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that Gordon Ringold, PhD has …

Renovamen Advisors® Launches to Help Early-Stage Biotechs Translate Breakthroughs into Scalable, Investable Business Models

Renovamen Advisors® Launches to Help Early-Stage Biotechs Translate Breakthroughs into Scalable, Investable Business Models

Renovamen Advisors® Launches to Help Early-Stage Biotechs Translate Breakthroughs into Scalable, Investable Business Models Guiding biotech teams from scientific breakthroughs to commercial inflection with investor-grade strategy and execution Chicago, IL …

nCino launches ProBanker by FullCircl, a new solution to help UK lenders identify opportunity and manage risk across their business portfolios

nCino launches ProBanker by FullCircl, a new solution to help UK lenders identify opportunity and manage risk across their business portfolios

LONDON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced the general availability of ProBanker by FullCircl. FullCircl, a technology acquired by nCino last …

Valneva Reports Further Positive Phase 2 Safety and Immunogenicity Results for Lyme Disease Vaccine Candidate

Valneva Reports Further Positive Phase 2 Safety and Immunogenicity Results for Lyme Disease Vaccine Candidate

Strong immune response after third yearly booster dose in children and adults Significant anamnestic antibody response across all six serotypes No safety concerns observed in any age group by independent Data Monitoring Committee (DMC), consistent with …

Valneva annonce de nouvelles données positives d’innocuité et d’immunogénicité de Phase 2 pour le candidat vaccin contre la maladie de Lyme

Valneva annonce de nouvelles données positives d’innocuité et d’immunogénicité de Phase 2 pour le candidat vaccin contre la maladie de Lyme

 Forte réponse immunitaire chez les enfants et les adultes après la troisième vaccination annuelle de rappel Forte réponse anamnestique observée pour les six sérotypes Aucun problème de sécurité observé dans toutes les tranches d’âge par le comité …

NMD Pharma Expands Senior Leadership Team with the Appointment of Ana de Vera as Chief Medical Officer

NMD Pharma Expands Senior Leadership Team with the Appointment of Ana de Vera as Chief Medical Officer

NMD Pharma Expands Senior Leadership Team with the Appointment of Ana de Vera as Chief Medical Officer Seasoned clinical development leader brings deep expertise in neuromuscular disease research, drug development, and commercialization in the US and …

ASK4SAM Cements Role As Best NYC Personal Injury Lawyers for Car Accidents in Queens & Bronx with 550th Google Review

ASK4SAM Cements Role As Best NYC Personal Injury Lawyers for Car Accidents in Queens & Bronx with 550th Google Review

Jamaica, NY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Silberstein …

Conversational AI Interview Tools Rolled Out to Streamline High-Volume Tech Hiring

Conversational AI Interview Tools Rolled Out to Streamline High-Volume Tech Hiring

Photo Courtesy of: Supportwave LONDON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Supportwave, a next-generation Tech staffing company, has launched a conversational interview platform aimed at overhauling technical hiring for enterprise clients. The platform …

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock

RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions